Locations
Seattle, WA, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Other
founded in
2015
Twin Strand Biosciences is a Seattle-based biotechnology company that specializes in improving DNA sequencing accuracy through its proprietary Duplex Sequencing technology. This technology offers over 10,000 times greater sensitivity, enabling the detection of mutations that are often invisible to standard methods. Their products, including the AML Assay and Mutagenesis Assay, cater to various applications in oncology, infectious disease, organ transplantation, and genetic health. The company is committed to advancing genomic research and medicine through internal projects and collaborations, positioning itself as a leader in the biotechnology sector with a strong focus on responsible scientific practices.
Something looks off?